The Cigna Group (NYSE:CI) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now.
Image by Alexsander-777 from Pixabay
The Cigna Group (NYSE:CI) is an American multinational company that provides managed healthcare and insurance services.
On October 14, Goldman Sachs analyst Scott Fidel initiated coverage of The Cigna Group (NYSE:CI) with a Buy rating and a price target of $370. In his note, he stated that the managed care sector is experiencing its steepest underwriting downturn in more than 15 years. Goldman Sachs recommends greater exposure to Medicare Advantage, anticipating a margin recovery phase starting in 2026, though it expects that rebound to vary across the industry. The firm also projects a slower recovery for Medicaid and the healthcare exchange markets.
The Cigna Group (NYSE:CI) has also drawn investor interest after Wells Fargo raised its price target on the stock to $354 from $340 on October 7 while maintaining an Equal Weight rating. The firm made this adjustment as part of its updated outlook for the sector ahead of Q3 2025 earnings, noting that the extension of enhanced subsidies now seems more probable.
The Cigna Group (NYSE:CI) continues to appeal to income-focused investors as well, with the company having raised its dividend for five consecutive years. It currently offers a quarterly dividend of $1.51 per share and has a dividend yield of 2.00%, as of October 14.
While we acknowledge the potential of CI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 11 Low PE High Dividend Stocks to Buy According to Analysts and 12 Reliable Dividend Stocks for Maximum Income.
Disclosure: None.
-1024x679.jpg "Illegal Immigration Is Down, but Fentanyl Seizures Are Up")
